Diagnostic, Disease and Pharmaceutical - Diagnostic Imaging Brief

Telix inks distribution deal for Zircaix

AuntMinnie

SEPTEMBER 18, 2024

Telix Pharmaceuticals has selected Cardinal Health to distribute its PET agent TLX250-CDx (Zircaix) for imaging kidney cancer in the U.S., In a recent phase III trial , the radiotracer was shown to be safe and effective for identifying small lesions, which could allow for earlier diagnosis of the disease. the company noted.

Pharmaceutical

Pharmaceutical Disease Diagnostic IT

FDA fast-tracks Clarity’s prostate cancer treatment

AuntMinnie

FEBRUARY 19, 2025

Clarity Pharmaceuticals has secured fast-track designation from the U.S. The classification builds on Clarity's earlier receipt of fast-track designation for its PET diagnostic imaging agent Cu-64 SAR-bisPSMA for identifying patients with the disease.

Radiopharmaceuticals

Radiopharmaceuticals Pharmaceutical Disease Diagnostic Imaging

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

AuntMinnie

AUGUST 5, 2024

Imagine going in for a diagnostic MRI scan and coming out with a progressive, irreversible, and potentially fatal disease. It certainly doesn't help matters that the disease has been linked to gadolinium-based contrast agents, a ubiquitous tool in the MR armamentarium. In 2006 the U.S. Louis hospital.

Disease

Disease MRI Radiologist X-ray

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology

A milestone for imaging in MASH diagnosis, treatment and monitoring

AuntMinnie

JUNE 14, 2024

For those unfamiliar with steatotic liver disease, this is important because Rezdiffra is the first approved treatment for MASH, which if left untreated can progress to cirrhosis, require liver transplantation, and potentially cause death. Rajarshi Banerjee, MD, PhD.

Imaging

Imaging Imaging Modalities Disease Medical Imaging

New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023

AuntMinnie

DECEMBER 1, 2023

The research will produce technical feedback to assist GEHC in assessing the system’s reconstruction methods, image presentation workflow, and clinical benefits for specific pathologies and disease types. MRI GEHC unveiled Signa Champion, a 1.5-tesla,

Healthcare

Healthcare Healthcare X-ray Ultrasound

Proscia Announces Update to AI-enabled Cloud-based Workflow Solution for Pathologists

Imaging Technology

JULY 24, 2024

Not for use in diagnostic procedures. “We Ballakur added, “It gives them the features they need to scale their use of AI-enabled pathology and capitalize on the latest innovations that shape our understanding of disease.” Concentriq AP is for research use only. Today’s news comes on the heels of a series of announcements from Proscia.

DICOM

DICOM Pharmaceutical Diagnostic Disease

New AI Tool Could Help Identify Dementia Risk

Imaging Technology

JANUARY 21, 2025

The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.

Pharmaceutical

Pharmaceutical Public Health Disease Diagnose

GE HealthCare Announces Agreement to Acquire MIM Software

Imaging Technology

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Healthcare

Healthcare Healthcare Radiation Oncology Radiation

AuntMinnie 2017: Pull linear MRI contrast from market, European group says

AuntMinnie

OCTOBER 11, 2024

The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals. The PRAC noted that no clinical diseases or even symptoms have been reported in connection with gadolinium deposition.

MRI

MRI Radiologist Diagnostic Pharmaceutical

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Imaging Technology

JULY 25, 2023

milla1cf Tue, 07/25/2023 - 20:22 July 25, 2023 — Ratio Therapeutics Inc. By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers.

Radiopharmaceuticals

Radiopharmaceuticals Imaging Pharmaceutical Disease

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In Our track record of success includes our program to supply U.S.-produced,

Medical

Medical Radiopharmaceuticals Pharmaceutical Radiation

Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

Imaging Technology

JULY 25, 2024

a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. christine.book Thu, 07/25/2024 - 12:44 July 25, 2024 — Immunis, Inc. ,

MRI

MRI Pharmaceutical Disease Clinic

Proscia Receives FDA Clearance for Digital Pathology Software Solution

Imaging Technology

FEBRUARY 12, 2024

Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).

Pharmaceutical

Pharmaceutical Clinic Diagnostic IT

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. This includes MIMneuro , which offers quantification solutions for dopamine transporter imaging and amyloid imaging.

Healthcare

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

MAY 25, 2023

Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S.,

Clinic

Clinic Healthcare Healthcare Imaging

InMed AI Receives FDA 510(k) clearance for NeuroShield

Imaging Technology

NOVEMBER 20, 2023

In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. The segmentation analysis revealed remarkable accuracy, reliability, and effectiveness of NeuroShield. Globally, over a billion people suffer from neurodegenerative disorders.

Pharmaceutical

Pharmaceutical Healthcare Healthcare Medical Device

First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Imaging Technology

JULY 11, 2023

We are delighted by our collaboration with Ratio Therapeutics in advancing the clinical development of RTX-1363S as a FAP-targeted diagnostic to the clinic," stated Etienne Montagut, Lantheus' Chief Business Officer. "By milla1cf Tue, 07/11/2023 - 09:02 July 11, 2023 — Ratio Therapeutics Inc.

Radiopharmaceuticals

Radiopharmaceuticals Imaging Pharmaceutical Disease

Proscia and Nucleai Partner To Broaden Access To AI Predictive Biomarkers

Imaging Technology

JULY 3, 2024

The rise of precision medicine is putting new pressures on diagnostic laboratories to tap into their pathology data, as whole slide images are among the best representations of disease. The same spatial mapping will also enable Nucleai’s applications to serve as companion diagnostics that match patients to the most effective treatment.

Pharmaceutical

Pharmaceutical Diagnostic Patient Care Clinic

GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology

Imaging Technology

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc.,

Interventional Radiology

Interventional Radiology Clinic Healthcare Healthcare

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

Imaging Technology

JULY 25, 2023

ii More information: www.bracco.com VUEWAY injection is now available to order from Bracco Diagnostics Inc. Avoid use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities. Manufactured for Bracco Diagnostics Inc. NJ: Bracco Diagnostics Inc.;

MRI

MRI Magnetic Resonance Imaging Imaging Diagnostic

Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal

REBEL EM

MAY 11, 2023

History of liver disease, history of substance abuse disorder, and history of delirium tremens were also extracted from the hospital EMR. CIWA scores or some other more universal diagnostic tool for alcohol withdrawal were not routinely used s o we have no idea why one patient got more than another.

Disease

Disease Medical Inpatient Hospital

NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical

MRI Teleradiology Reporting; Viable Solution for Tier 2, Tier 3 Cities & Rural India

Future Teleradiology

APRIL 3, 2020

Also, the new online pharmaceutical retail industry is gradually penetrating the market. MRI scans offer many applications in the disease diagnosis like neuroscans, liver scans and cardiac. Further advancements in technology related to MRI have widened its scope to diagnose various diseases.

Teleradiology

Teleradiology MRI Government Hospital

Diagnostic Imaging Brief

Telix inks distribution deal for Zircaix

FDA fast-tracks Clarity’s prostate cancer treatment

Trending Sources

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

The rise of theranostics: Part 3 -- What is a theranostics center?

A milestone for imaging in MASH diagnosis, treatment and monitoring

New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023

Proscia Announces Update to AI-enabled Cloud-based Workflow Solution for Pathologists

New AI Tool Could Help Identify Dementia Risk

GE HealthCare Announces Agreement to Acquire MIM Software

AuntMinnie 2017: Pull linear MRI contrast from market, European group says

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

Proscia Receives FDA Clearance for Digital Pathology Software Solution

GE HealthCare Closes MIM Software Acquisition

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

InMed AI Receives FDA 510(k) clearance for NeuroShield

First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Proscia and Nucleai Partner To Broaden Access To AI Predictive Biomarkers

GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal

NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

MRI Teleradiology Reporting; Viable Solution for Tier 2, Tier 3 Cities & Rural India

Stay Connected